Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Traumatic

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44346   clinical trials with a EudraCT protocol, of which   7374   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  Next»
    Study title: Amantadine in Pediatric Patients with Traumatic Brain Injury: A Retrospective, Case-Controlled StudyAmantadine in Pediatric Patients with Traumatic Brain Injury: A Retrospective, Case-Controlled Study
    Active substance: AMANTADINE
    Study summary document link (including results):
    View full study record
    Document reference: 46491
    Study title: Amantadine treatment following traumatic brain injury in childrenAmantadine treatment following traumatic brain injury in children
    Active substance: AMANTADINE
    Study summary document link (including results):
    View full study record
    Document reference: 46493
    Study title: Dopamine agonist therapy in low-response children following traumatic brain injury.Dopamine agonist therapy in low-response children following traumatic brain injury.
    Active substance: AMANTADINE
    Study summary document link (including results):
    View full study record
    Document reference: 46501
    Study title: Neurobehavioral effects of amantadine after pediatrics traumatic brain injury Neurobehavioral effects of amantadine after pediatrics traumatic brain injury
    Active substance: AMANTADINE
    Study summary document link (including results):
    View full study record
    Document reference: 46510
    Study title: 3.) Oral Enzyme Therapy in the Treat- ment and Prophy- laxis of Posttraumatic and Postperative Swelling
    Active substance: Bromelain (HERB) Trypsin Rutosid • 3 H2O
    Study summary document link (including results):
    View full study record
    Document reference: 39810
    Study title: Enzyme Therapy as Antidematous and anti-inflammatory Therapy of traumatic Injuries in children
    Active substance: Bromelain (HERB) Trypsin Rutosid • 3 H2O
    Study summary document link (including results):
    View full study record
    Document reference: 39809
    Study title: Percutaneous puncture and pre-operative cyanoacrylate obliteration of a traumatic false aneurysm of an angular artery branch.
    Active substance: Ethyl esters of iodized fatty acids of poppy seed oil
    Study summary document link (including results):
    View full study record
    Document reference: 39913
    Study title: Emergency endovascular embolization of traumatic intrarenal arterial pseudoaneurysms with N-Butyl cyanoacrylate.
    Active substance: Ethyl esters of iodized fatty acids of poppy seed oil
    Study summary document link (including results):
    View full study record
    Document reference: 39914
    Study title: Controlled study of Voltaren Emulgel 1% in post traumatic conditions of the locomotive apparatusControlled study of Voltaren Emulgel 1% in post traumatic conditions of the locomotive apparatus
    Active substance: DICLOFENAC
    Study summary document link (including results):
    View full study record
    Document reference: 26016
    Study title: Van Husen H. Effect of DR 1200/1 in “posttraumatic” disease. February 12, 1985. (2 paediatric patients, both age 13 years) Van Husen H. Effect of DR 1200/1 in “posttraumatic” disease. February 12, 1985. (2 paediatric patients, both age 13 years)
    Active substance: DICLOFENAC
    Study summary document link (including results): Voltaren Ophtha Paediatric Studies_Van Husen 12-Feb-1985_EMA spreadsheet.xls
    View full study record
    Document reference: 26053
    Study title: Cander B, et all.The effectiveness of analgesics in traumatic injuries of the extremities. Adv Ther. 2005 Sep-Oct;22(5):462-6.Cander B, et all.The effectiveness of analgesics in traumatic injuries of the extremities. Adv Ther. 2005 Sep-Oct;22(5):462-6.
    Active substance: DICLOFENAC
    Study summary document link (including results):
    View full study record
    Document reference: 25979
    Study title: Cander B, et all.The effectiveness of analgesics in traumatic injuries of the extremities. Adv Ther. 2005 Sep-Oct;22(5):462-6.Cander B, et all.The effectiveness of analgesics in traumatic injuries of the extremities. Adv Ther. 2005 Sep-Oct;22(5):462-6.
    Active substance: DICLOFENAC
    Study summary document link (including results):
    View full study record
    Document reference: 25990
    Study title: Tolerability of nimesulide and ketoprofen in paediatric patients with traumatic or surgical fracture - Facchini R., Selva G., Peretti G. - 1993 ( Drugs 1993, 46, Suppl. 1, p. 238)
    Active substance: KETOPROFEN
    Study summary document link (including results):
    View full study record
    Document reference: 30874
    Study title: Bylander B, Hansson LI, Kärrholm J, Naversten Y. Scintimetric evaluation of posttraumatic and postoperative growth disturbance using 99Tcm MDP. Acta Radiol Diagn (Stockh). 1983;24(1):85-96. Bylander B, Hansson LI, Kärrholm J, Naversten Y. Scintimetric evaluation of posttraumatic and postoperative growth disturbance using 99Tcm MDP. Acta Radiol Diagn (Stockh). 1983;24(1):85-96.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 44058
    Study title: Acta Neurochir Suppl. 2005;95:165-8. Glucose metabolism in traumatic brain injury: a combined microdialysis and [18F]-2-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) study. O'Connell MT, Seal A, Nortje J, Al-Rawi PG, Coles JP, Fryer TD, Menon DK, Pickard JD, Hutchinson PJ.
    Active substance: FLUDEOXYGLUCOSE
    Study summary document link (including results):
    View full study record
    Document reference: 28090
    Study title: Emergency endovascular embolization of traumatic intrarenal arterial pseudoaneurysms with N-Butyl cyanoacrylate. 02/12/2010Emergency endovascular embolization of traumatic intrarenal arterial pseudoaneurysms with N-Butyl cyanoacrylate. 02/12/2010
    Active substance: IODINE
    Study summary document link (including results):
    View full study record
    Document reference: 30243
    Study title: Percutaneous puncture and pre-operative cyanoacrylate obliteration of a traumatic false aneurysm of an angular artery branch. ;Huang-F. British Journal of Radiology, 2003, Vol/Iss/Pg. 76/910 (746-749)Percutaneous puncture and pre-operative cyanoacrylate obliteration of a traumatic false aneurysm of an angular artery branch. ;Huang-F. British Journal of Radiology, 2003, Vol/Iss/Pg. 76/910 (746-749)
    Active substance: IODINE
    Study summary document link (including results):
    View full study record
    Document reference: 30300
    Study title: Scintimetric evaluation of posttraumatic and postoperative growth disturbance using 99Tcm MDP.Bylander B, Hansson LI, Kärrholm J, Naversten Y. Acta Radiol Diagn 1983;24(1):85-96.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 48587
    Study title: O'Connell MT, Seal A, Nortje J, Al-Rawi PG, Coles JP, Fryer TD, et al.. Glucose metabolism in traumatic brain injury: a combined microdialysis and [18F]-2-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) study. [oconnell-2005]Acta Neurochir Suppl. 2005;95:165-8. O'Connell MT 2005
    Active substance: Steripet
    Study summary document link (including results): 2011-09 GE response Template List of published articles.doc
    View full study record
    Document reference: 48686
    Study title: [The age dependence of traumatically induced bone remodeling as studied in the bone scintigram] German Spitz J, Lauer I, Tittel K. Nuklearmedizin. 1991 Oct;30(5):155-60. German.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43726
    1  2  Next»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri Jun 27 17:06:52 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA